Vimarsana
Biggest News Aggregation in the World

Page 12 - Project Bioshield News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Project Bioshield. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Project Bioshield Today - Breaking & Trending Today

Soligenix Receives Refusal to File Letter from U.S. FDA for HyBryte™ New Drug Application in the Treatment of Cutaneous T-Cell Lymphoma - Vimarsana News

Soligenix Receives Refusal to File Letter from U.S. FDA for HyBryte™ New Drug Application in the Treatment of Cutaneous T-Cell Lymphoma

/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...

Robert Kadlec's 20-Year Plot - Vimarsana News

Robert Kadlec's 20-Year Plot

Commentary When it comes to the business of vaccines and biosecurity, the land of free enterprise is all ...

Soligenix Announces Reverse Stock Split - Vimarsana News

Soligenix Announces Reverse Stock Split

/PRNewswire/ -- Soligenix, Inc. (NASDAQ: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...

Soligenix Invited to Present at the Virtual Investor Summit Event - Vimarsana News

Soligenix Invited to Present at the Virtual Investor Summit Event

/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...

Soligenix Announces Distribution of Series D Preferred Stock to Holders of its Common Stock - Vimarsana News

Soligenix Announces Distribution of Series D Preferred Stock to Holders of its Common Stock

/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...